
Algorithmic Biologic's vision is to create a bountiful and healthy world by bringing scale efficiencies to molecular discovery and diagnostics.
AlgoBio is bringing scale efficiencies to molecular discovery and diagnostics through our cloud-hosted software platform Tapestry. Our founder is an IIT Bombay professor-turned-entrepreneur and a leading researcher in the field of Molecular Computing who has been awarded the Ramanujan Fellowship and the Viterbi Graduate Fellowship. In our short journey of 18 months since incorporation, AlgoBio has built up a great team with 4 PhDs, filed 5 patent applications, obtained CE-IVD mark for our software platform Tapestry, reached top-10 finals of the XPRIZE from 350+ international teams, won the Elevate prize from Government of Karnataka, won the AMR-Quest challenge conducted by CCAMP from a field of 269 teams, and been featured in lists of top deep tech startups and top AI startups. Axilor Ventures has invested in the company. Our commercial engagements include partnerships with industry leaders like MedGenome, Mahyco, Molbio Diagnostics, as well as with academic research institutions like IGIB.
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
Frequently Asked Questions
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.